Indonesia stands as a key pharmaceutical market in Southeast Asia, driven by demographic scale, improving healthcare access, and rising demand for innovative and generic pharmaceutical products.
However, market entry is strictly regulated so any pharmaceutical product intended to be manufactured, imported, distributed, or marketed must undergo Indonesia drug registration before it can be legally sold.
The registration process is comprehensive and highly technical, focusing on safety, quality, and efficacy.
For both local manufacturers and foreign pharmaceutical companies, understanding Indonesia drug registration process is essential to avoid rejection, delays, or enforcement risks.
Definition of Drugs Under Indonesian Law
Under Indonesian law, drugs are defined as substances or combinations of substances used to diagnose, prevent, relieve, treat, or cure diseases, or to influence physiological systems in humans.
This definition is broad and covers a wide range of pharmaceutical products.
Drugs regulated in Indonesia include:
- Prescription medicines
- Over-the-counter (OTC) medicines
- Generic and branded pharmaceutical products
- Vaccines and biological products
- Certain traditional medicines with therapeutic claims
Any product that makes medical or therapeutic claims, regardless of dosage form, may be classified as a drug.
This distinction is critical as misclassification is one of the most common reasons applications fail during Indonesia drug registration.
Meanwhile, regulatory oversight of drugs is managed by Badan Pengawas Obat dan Makanan (BPOM) which acts as Indonesia’s national drug regulatory authority.
Drug Classification in Indonesia
Drug classification plays a central role in determining registration requirements, dossier depth, and review timelines.
BPOM categorizes drugs based on risk level, therapeutic use, and distribution control as followed:
- Prescription Drugs
Prescription drugs are medicines that can only be dispensed with a valid prescription from a licensed healthcare professional.
These products are subject to the most rigorous regulatory review, including extensive clinical data and pharmacovigilance obligations.
- Over-the-Counter (OTC) Drugs
OTC drugs are medicines deemed safe for use without direct medical supervision when used according to labeling instructions.
Although regulatory requirements are less extensive than prescription drugs, OTC products must still demonstrate safety, quality, and appropriate labeling.
- Generic Drugs
Generic drugs contain the same active ingredients, strength, dosage form, and route of administration as reference products.
Indonesia promotes the use of generics, but registration still requires bioequivalence data and compliance with Good Manufacturing Practice (GMP).
- New Drugs and Innovative Products
New chemical entities, biological products, and vaccines are classified as high-risk and require full clinical development data.
These products undergo the most comprehensive review during Indonesia drug registration.
Indonesia Drug Registration Requirements
Successfully completing Indonesia drug registration requires the preparation of a detailed regulatory dossier that meets BPOM’s technical standards.
The requirements include:
- Legal and Administrative Requirements
Only an Indonesian legal entity may hold a drug registration.
Foreign pharmaceutical companies must establish a local subsidiary or appoint a licensed local partner as the Marketing Authorization Holder (MAH).
Required administrative documents typically include:
- Company legal documents and licenses
- Appointment letter or authorization from the manufacturer
- GMP certificates for manufacturing sites
- Certificate of Pharmaceutical Product (CPP) or equivalent
- Dossier Requirements (CTD Format)
BPOM generally follows the Common Technical Document (CTD) structure, although local adaptations apply. The dossier is divided into five modules:
- Module 1: Administrative and Prescribing Information
Includes application forms, labeling, package inserts, and legal documents.
- Module 2: Summaries
Provides quality, non-clinical, and clinical overviews and summaries.
- Module 3: Quality (CMC)
Details active pharmaceutical ingredient (API) and finished product manufacturing, specifications, stability data, and quality control procedures.
- Module 4: Non-Clinical Study Reports
Includes pharmacology, toxicology, and safety studies.
- Module 5: Clinical Study Reports
Contains clinical trial data demonstrating safety and efficacy. For generics, this module may be replaced by bioequivalence studies.
- Clinical Data Requirements
Clinical data requirements depend on product classification:
- New drugs require full clinical trial data
- Generics require bioequivalence studies
- OTC products may rely on published literature and safety data
BPOM may require local clinical trials in Indonesia, particularly for certain therapeutic classes or high-risk products.
Steps to Obtain Indonesia Drug Registration
Understanding the step-by-step process is essential to managing timelines and expectations during Indonesia drug registration. The process itself runs as follow:
Step 1: Pre-Submission Preparation
Before submission, your company must confirm product classification, identify data gaps, and ensure all documents comply with BPOM requirements. Many applicants conduct a regulatory gap analysis at this stage to minimize rejection risks.
Step 2: Online Application Submission
Applications are submitted through BPOM’s electronic registration system. Administrative screening is conducted to verify document completeness and format compliance.
Step 3: Administrative Evaluation
BPOM reviews legal documents, manufacturer authorizations, and GMP certificates. Applications that fail administrative review are returned for correction.
Step 4: Technical Evaluation
This is the most time-consuming stage. BPOM evaluates quality, safety, and efficacy data in detail. Reviewers may issue queries requesting clarification or additional data.
Step 5: Query Response and Clarification
Every applicant must respond to BPOM queries within specified deadlines. Keep in mind that clear, well-supported responses are critical to maintaining progress and avoiding delays.
Step 6: Approval and Marketing Authorization
Once BPOM is satisfied, a marketing authorization is issued. The product may then be legally manufactured, imported, and distributed in Indonesia.
Furthermore, the timeline for Indonesia drug registration varies significantly depending on product type and dossier completeness, such as:
- Generic drugs; approximately 12–18 months
- OTC drugs; approximately 8–12 months
- New drugs and biologics; 18–36 months or longer
Once approved, marketing authorizations are typically valid for five years and must be renewed before expiration.
Any post-approval changes, such as formulation updates or manufacturing site changes, require regulatory notification or approval.
Watershore, Your Reliable Partner for Indonesia Drug Registration
Indonesia drug registration is a complex, highly regulated process that demands technical precision, regulatory knowledge, and careful planning.
That being the case, partnering with experienced regulatory advisors like Watershore enables your pharmaceutical company to navigate Indonesia drug registration efficiently and confidently.
From researching specific licenses to preparing and submitting paperwork, we provide ample assistance to ensure a smooth process.
With our expertise, navigating the intricate regulatory requirements becomes effortless.
We save you time and effort while ensuring legal compliance, so you can focus on growing your business with confidence.
Get in touch with Watershore today or connect with us via WhatsApp so your products can reach patients safely and legally in the Indonesian market!
Sources:
https:// baipharm.chemlinked.com/insights/indonesia-drug-registration-pathway#:~:text=Before%20entering%20the%20registration%20stage,Drug%20registration%20timeline%20in%20Indonesia
https:// www.biospectrumasia.com/regulatory/25/7633/how-to-get-your-drug-registered-in-indonesia.html
Image source:
https:// www.freepik.com/free-photo/man-hazmat-suit-with-medicine-pills_7346872.htm#fromView=search&page=1&position=10&uuid=36109f38-998d-44d3-852b-69dc8958b66c&query=drug+registration